Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Frontiers in Pharmacology|August 29, 2022
Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathwayLei Wang, Wuxiyar Otkur, Aman Wang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 24, 2003
[Phase II clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer]Shu-jun Liu, Li-jun Di, Jie Wang, et al.International Journal of Clinical and Experimental Pathology|November 18, 2014
DSTYK kinase domain ablation impaired the mice capabilities of learning and memory in water maze testKui Li, Ji-Wei Liu, Zhi-Chuan Zhu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 25, 2003
[Clinical trial on exemestane in the treatment of postmenopausal women with advanced breast cancer]Xiao-qing Liu, San-tai Song, Ji-wei Liu, et al.Neuroscience Bulletin|October 12, 2024
Loss of TET Activity in the Postnatal Mouse Brain Perturbs Synaptic Gene Expression and Impairs Cognitive FunctionJi-Wei Liu, Ze-Qiang Zhang, Zhi-Chuan Zhu, et al.Journal of Translational Medicine|April 16, 2021
Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysisLu-Ping Yang, Zi-Xian Wang, Rui Zhang, et al.Oncogene|September 13, 2019
An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteasesDi Chen, Zhen Ning, Huan Chen, et al.Transboundary and Emerging Diseases|February 9, 2026
Engineered VP1 mRNA Vaccine Induces Immunity and Complete Protection Against Feline Calicivirus in CatsMeng-Di Zhang, Zhuo-Fang Xie, Xin-Hong Li, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 1, 2006
[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]Jun-ling Li, Xiang-ru Zhang, Ji-wei Liu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 1, 2006
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors]Pin Zhang, Feng-yi Feng, Ling-ying Wu, et al.Pageof 7